JCR Acquiring ArmaGen to Expedite Drug Development for Lysosomal Diseases

March 27, 2020
JCR Pharmaceuticals said on March 26 that it will acquire San Diego biotech ArmaGen for an undisclosed sum in a bid to speed up global drug development for lysosomal storage disorders, with the transaction expected to be completed in late...read more